Answer
No. The selected pre-filled syringe is licensed for adult osteoporosis and specified bone-loss conditions, while the selected vial is licensed for advanced malignancy involving bone and selected giant cell tumours.
Sources for this answer
- Obodence 60 mg solution for injection in pre-filled syringe — Current selected SmPCemc · Summary of Product Characteristics
- Osenvelt 120mg vial — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.